Samoa

Samoa

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
5.24 (4.25 - 6.30) 2019 Modelled IHME
5.34 (4.37 - 6.44) 2018 Modelled IHME
5.48 (4.46 - 6.65) 2017 Modelled IHME
5.72 (4.63 - 6.88) 2016 Modelled IHME
5.89 (4.73 - 7.01) 2015 Modelled IHME
5.89 (4.71 - 7.08) 2014 Modelled IHME
5.88 (4.69 - 7.11) 2013 Modelled IHME
5.87 (4.63 - 7.10) 2012 Modelled IHME
5.86 (4.60 - 7.19) 2011 Modelled IHME
5.86 (4.58 - 7.29) 2010 Modelled IHME
5.91 (4.65 - 7.33) 2009 Modelled IHME
6.02 (4.77 - 7.43) 2008 Modelled IHME
6.14 (4.92 - 7.57) 2007 Modelled IHME
6.25 (5.02 - 7.66) 2006 Modelled IHME
6.29 (5.07 - 7.69) 2005 Modelled IHME
6.27 (5.05 - 7.61) 2004 Modelled IHME
6.21 (5.02 - 7.52) 2003 Modelled IHME
6.14 (4.97 - 7.40) 2002 Modelled IHME
6.07 (4.89 - 7.31) 2001 Modelled IHME
6.05 (4.87 - 7.31) 2000 Modelled IHME
6.1 (4.92 - 7.36) 1999 Modelled IHME
6.21 (4.99 - 7.51) 1998 Modelled IHME
6.34 (5.07 - 7.70) 1997 Modelled IHME
6.46 (5.15 - 7.92) 1996 Modelled IHME
6.5 (5.15 - 8.10) 1995 Modelled IHME
6.5 (5.18 - 8.05) 1994 Modelled IHME
6.47 (5.18 - 7.96) 1993 Modelled IHME
6.42 (5.17 - 7.83) 1992 Modelled IHME
6.35 (5.09 - 7.75) 1991 Modelled IHME
6.25 (5.01 - 7.56) 1990 Modelled IHME
3.33 (2.03 - 5.18) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.99 (1.31 - 2.76) 2019 Modelled IHME
2.04 (1.33 - 2.75) 2018 Modelled IHME
2.1 (1.36 - 2.92) 2017 Modelled IHME
2.23 (1.43 - 3.05) 2016 Modelled IHME
2.33 (1.47 - 3.19) 2015 Modelled IHME
2.33 (1.46 - 3.19) 2014 Modelled IHME
2.32 (1.45 - 3.19) 2013 Modelled IHME
2.31 (1.44 - 3.20) 2012 Modelled IHME
2.3 (1.42 - 3.22) 2011 Modelled IHME
2.3 (1.42 - 3.30) 2010 Modelled IHME
2.33 (1.45 - 3.32) 2009 Modelled IHME
2.42 (1.54 - 3.37) 2008 Modelled IHME
2.51 (1.63 - 3.47) 2007 Modelled IHME
2.6 (1.70 - 3.53) 2006 Modelled IHME
2.63 (1.75 - 3.59) 2005 Modelled IHME
2.58 (1.71 - 3.51) 2004 Modelled IHME
2.46 (1.61 - 3.37) 2003 Modelled IHME
2.31 (1.52 - 3.19) 2002 Modelled IHME
2.19 (1.44 - 3.05) 2001 Modelled IHME
2.14 (1.40 - 3.01) 2000 Modelled IHME
2.14 (1.41 - 2.98) 1999 Modelled IHME
2.15 (1.41 - 2.98) 1998 Modelled IHME
2.17 (1.42 - 2.99) 1997 Modelled IHME
2.19 (1.44 - 3.02) 1996 Modelled IHME
2.21 (1.47 - 3.04) 1995 Modelled IHME
2.26 (1.50 - 3.09) 1994 Modelled IHME
2.35 (1.56 - 3.21) 1993 Modelled IHME
2.48 (1.64 - 3.39) 1992 Modelled IHME
2.62 (1.72 - 3.61) 1991 Modelled IHME
2.78 (1.81 - 3.83) 1990 Modelled IHME
1.05 (0.56 - 1.72) 2015 Modelled WHO
0.1 2014 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
10,221 (8,197 - 12,368) 1990 Modelled IHME
10,427 (8,362 - 12,719) 1991 Modelled IHME
10,589 (8,525 - 12,910) 1992 Modelled IHME
10,715 (8,585 - 13,176) 1993 Modelled IHME
10,812 (8,631 - 13,394) 1994 Modelled IHME
10,887 (8,618 - 13,555) 1995 Modelled IHME
10,876 (8,679 - 13,348) 1996 Modelled IHME
10,758 (8,599 - 13,053) 1997 Modelled IHME
10,604 (8,530 - 12,820) 1998 Modelled IHME
10,486 (8,466 - 12,657) 1999 Modelled IHME
10,478 (8,436 - 12,656) 2000 Modelled IHME
10,594 (8,529 - 12,749) 2001 Modelled IHME
10,769 (8,715 - 12,988) 2002 Modelled IHME
10,963 (8,860 - 13,275) 2003 Modelled IHME
11,136 (8,972 - 13,529) 2004 Modelled IHME
11,248 (9,060 - 13,744) 2005 Modelled IHME
11,236 (9,027 - 13,775) 2006 Modelled IHME
11,114 (8,906 - 13,688) 2007 Modelled IHME
10,959 (8,688 - 13,538) 2008 Modelled IHME
10,843 (8,534 - 13,454) 2009 Modelled IHME
10,851 (8,485 - 13,495) 2010 Modelled IHME
10,972 (8,608 - 13,464) 2011 Modelled IHME
11,132 (8,787 - 13,470) 2012 Modelled IHME
11,315 (9,023 - 13,672) 2013 Modelled IHME
11,508 (9,206 - 13,822) 2014 Modelled IHME
11,694 (9,390 - 13,916) 2015 Modelled IHME
11,540 (9,344 - 13,874) 2016 Modelled IHME
11,230 (9,140 - 13,632) 2017 Modelled IHME
11,121 (9,088 - 13,409) 2018 Modelled IHME
11,079 (8,984 - 13,316) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.53 (5.52 - 10) 2019 Modelled IHME
7.61 (5.59 - 10.10) 2018 Modelled IHME
7.65 (5.58 - 10.10) 2017 Modelled IHME
7.65 (5.61 - 10) 2016 Modelled IHME
7.65 (5.64 - 9.99) 2015 Modelled IHME
7.62 (5.64 - 10) 2014 Modelled IHME
7.58 (5.64 - 9.89) 2013 Modelled IHME
7.56 (5.63 - 9.85) 2012 Modelled IHME
7.51 (5.61 - 9.79) 2011 Modelled IHME
7.49 (5.60 - 9.80) 2010 Modelled IHME
7.5 (5.61 - 9.85) 2009 Modelled IHME
7.49 (5.59 - 9.81) 2008 Modelled IHME
7.47 (5.52 - 9.77) 2007 Modelled IHME
7.45 (5.47 - 9.97) 2006 Modelled IHME
7.41 (5.45 - 10.10) 2005 Modelled IHME
7.41 (5.45 - 10.10) 2004 Modelled IHME
7.45 (5.46 - 10.20) 2003 Modelled IHME
7.5 (5.45 - 10.20) 2002 Modelled IHME
7.59 (5.53 - 10.40) 2001 Modelled IHME
7.68 (5.61 - 10.50) 2000 Modelled IHME
7.74 (5.62 - 10.50) 1999 Modelled IHME
7.74 (5.62 - 10.54) 1998 Modelled IHME
7.78 (5.60 - 10.50) 1997 Modelled IHME
7.83 (5.60 - 10.70) 1996 Modelled IHME
7.89 (5.64 - 10.80) 1995 Modelled IHME
7.94 (5.80 - 10.80) 1994 Modelled IHME
8.02 (5.91 - 10.90) 1993 Modelled IHME
8.12 (5.94 - 11) 1992 Modelled IHME
8.21 (5.94 - 11.20) 1991 Modelled IHME
8.26 (5.93 - 11.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
16 (12 - 21) 2019 Modelled IHME
16 (12 - 21) 2018 Modelled IHME
16 (11 - 21) 2017 Modelled IHME
15 (11 - 20) 2016 Modelled IHME
15 (11 - 20) 2015 Modelled IHME
15 (11 - 20) 2014 Modelled IHME
15 (11 - 19) 2013 Modelled IHME
14 (11 - 19) 2012 Modelled IHME
14 (11 - 18) 2011 Modelled IHME
14 (10 - 18) 2010 Modelled IHME
14 (10 - 18) 2009 Modelled IHME
14 (10 - 18) 2008 Modelled IHME
14 (10 - 18) 2007 Modelled IHME
13 (10 - 18) 2006 Modelled IHME
13 (10 - 18) 2005 Modelled IHME
13 (10 - 18) 2004 Modelled IHME
13 (10 - 18) 2003 Modelled IHME
13 (10 - 18) 2002 Modelled IHME
13 (10 - 18) 2001 Modelled IHME
13 (10 - 18) 2000 Modelled IHME
13 (10 - 18) 1999 Modelled IHME
13 (10 - 18) 1998 Modelled IHME
13 (10 - 18) 1997 Modelled IHME
13 (9 - 18) 1996 Modelled IHME
13 (9 - 18) 1995 Modelled IHME
13 (10 - 18) 1994 Modelled IHME
13 (10 - 18) 1993 Modelled IHME
13 (10 - 18) 1992 Modelled IHME
13 (10 - 18) 1991 Modelled IHME
14 (10 - 18) 1990 Modelled IHME
13 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
55 (46 - 65) 2019 Modelled IHME
55 (46 - 64) 2018 Modelled IHME
55 (46 - 64) 2017 Modelled IHME
55 (46 - 64) 2016 Modelled IHME
55 (46 - 64) 2015 Modelled IHME
55 (46 - 64) 2014 Modelled IHME
55 (46 - 64) 2013 Modelled IHME
55 (46 - 64) 2012 Modelled IHME
55 (46 - 64) 2011 Modelled IHME
55 (46 - 64) 2010 Modelled IHME
55 (46 - 64) 2009 Modelled IHME
54 (46 - 64) 2008 Modelled IHME
54 (46 - 63) 2007 Modelled IHME
54 (46 - 63) 2006 Modelled IHME
54 (45 - 64) 2005 Modelled IHME
54 (46 - 63) 2004 Modelled IHME
55 (46 - 64) 2003 Modelled IHME
55 (46 - 64) 2002 Modelled IHME
55 (46 - 64) 2001 Modelled IHME
55 (46 - 64) 2000 Modelled IHME
55 (46 - 64) 1999 Modelled IHME
55 (46 - 64) 1998 Modelled IHME
55 (46 - 64) 1997 Modelled IHME
55 (45 - 64) 1996 Modelled IHME
55 (46 - 64) 1995 Modelled IHME
55 (46 - 65) 1994 Modelled IHME
55 (46 - 64) 1993 Modelled IHME
56 (46 - 65) 1992 Modelled IHME
56 (46 - 65) 1991 Modelled IHME
56 (46 - 65) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
46 2018 Survey/reported WHO/UNICEF
81 2017 Survey/reported WHO/UNICEF
77 2016 Survey/reported WHO/UNICEF
72 2015 Survey/reported WHO/UNICEF
69 2014 Survey/reported WHO/UNICEF
78 2013 Survey/reported WHO/UNICEF
83 2012 Survey/reported WHO/UNICEF
87 2011 Survey/reported WHO/UNICEF
78 2010 Survey/reported WHO/UNICEF
62 2009 Survey/reported WHO/UNICEF
68 2008 Survey/reported WHO/UNICEF
85 2007 Survey/reported WHO/UNICEF
58 2006 Survey/reported WHO/UNICEF
52 2005 Survey/reported WHO/UNICEF
45 2004 Survey/reported WHO/UNICEF
66 2003 Survey/reported WHO/UNICEF
86 2002 Survey/reported WHO/UNICEF
85 2001 Survey/reported WHO/UNICEF
86 2000 Survey/reported WHO/UNICEF
65 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
34 2018 Survey/reported WHO/UNICEF
74 2017 Survey/reported WHO/UNICEF
80 2016 Survey/reported WHO/UNICEF
84 2015 Survey/reported WHO/UNICEF
81 2014 Survey/reported WHO/UNICEF
85 2013 Survey/reported WHO/UNICEF
82 2012 Survey/reported WHO/UNICEF
75 2011 Survey/reported WHO/UNICEF
72 2010 Survey/reported WHO/UNICEF
58 2009 Survey/reported WHO/UNICEF
26 2008 Survey/reported WHO/UNICEF
58 2007 Survey/reported WHO/UNICEF
46 2006 Survey/reported WHO/UNICEF
51 2005 Survey/reported WHO/UNICEF
62 2004 Survey/reported WHO/UNICEF
90 2003 Survey/reported WHO/UNICEF
92 2002 Survey/reported WHO/UNICEF
93 2001 Survey/reported WHO/UNICEF
93 2000 Survey/reported WHO/UNICEF
97 1999 Survey/reported WHO/UNICEF
98 1998 Survey/reported WHO/UNICEF
99 1997 Survey/reported WHO/UNICEF
98 1996 Survey/reported WHO/UNICEF
96 1995 Survey/reported WHO/UNICEF
94 1994 Survey/reported WHO/UNICEF
1 1993 Survey/reported WHO/UNICEF
18 1992 Survey/reported WHO/UNICEF
58 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.28 (0.22 - 0.35) 2019 Modelled IHME
0.28 (0.22 - 0.34) 2018 Modelled IHME
0.28 (0.23 - 0.35) 2017 Modelled IHME
0.28 (0.23 - 0.35) 2016 Modelled IHME
0.29 (0.23 - 0.35) 2015 Modelled IHME
0.29 (0.23 - 0.35) 2014 Modelled IHME
0.29 (0.23 - 0.35) 2013 Modelled IHME
0.29 (0.23 - 0.36) 2012 Modelled IHME
0.29 (0.23 - 0.36) 2011 Modelled IHME
0.29 (0.23 - 0.36) 2010 Modelled IHME
0.28 (0.23 - 0.35) 2009 Modelled IHME
0.26 (0.21 - 0.32) 2008 Modelled IHME
0.24 (0.19 - 0.30) 2007 Modelled IHME
0.22 (0.18 - 0.27) 2006 Modelled IHME
0.21 (0.17 - 0.26) 2005 Modelled IHME
0.21 (0.17 - 0.26) 2004 Modelled IHME
0.21 (0.17 - 0.26) 2003 Modelled IHME
0.21 (0.17 - 0.26) 2002 Modelled IHME
0.21 (0.17 - 0.26) 2001 Modelled IHME
0.21 (0.17 - 0.26) 2000 Modelled IHME
0.22 (0.18 - 0.27) 1999 Modelled IHME
0.24 (0.19 - 0.30) 1998 Modelled IHME
0.26 (0.21 - 0.32) 1997 Modelled IHME
0.28 (0.23 - 0.35) 1996 Modelled IHME
0.29 (0.23 - 0.36) 1995 Modelled IHME
0.29 (0.23 - 0.36) 1994 Modelled IHME
0.29 (0.23 - 0.36) 1993 Modelled IHME
0.29 (0.23 - 0.36) 1992 Modelled IHME
0.29 (0.23 - 0.35) 1991 Modelled IHME
0.28 (0.22 - 0.35) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.2 (0.20 - 0.90) 2014 Modelled Gower et al, 2014
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
459 (364 - 573) 1990 Modelled IHME
468 (373 - 580) 1991 Modelled IHME
475 (380 - 586) 1992 Modelled IHME
480 (384 - 592) 1993 Modelled IHME
483 (385 - 595) 1994 Modelled IHME
486 (387 - 600) 1995 Modelled IHME
475 (380 - 586) 1996 Modelled IHME
446 (357 - 550) 1997 Modelled IHME
410 (331 - 506) 1998 Modelled IHME
379 (303 - 468) 1999 Modelled IHME
368 (293 - 457) 2000 Modelled IHME
370 (294 - 461) 2001 Modelled IHME
373 (298 - 463) 2002 Modelled IHME
375 (299 - 465) 2003 Modelled IHME
377 (301 - 469) 2004 Modelled IHME
379 (304 - 473) 2005 Modelled IHME
396 (320 - 491) 2006 Modelled IHME
433 (350 - 534) 2007 Modelled IHME
477 (386 - 589) 2008 Modelled IHME
515 (416 - 637) 2009 Modelled IHME
534 (429 - 661) 2010 Modelled IHME
540 (437 - 666) 2011 Modelled IHME
547 (441 - 674) 2012 Modelled IHME
555 (443 - 682) 2013 Modelled IHME
563 (449 - 690) 2014 Modelled IHME
571 (456 - 700) 2015 Modelled IHME
574 (462 - 704) 2016 Modelled IHME
576 (463 - 710) 2017 Modelled IHME
585 (468 - 715) 2018 Modelled IHME
595 (474 - 732) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.81 (2.67 - 5.26) 2019 Modelled IHME
3.81 (2.67 - 5.23) 2018 Modelled IHME
3.81 (2.67 - 5.25) 2017 Modelled IHME
3.81 (2.67 - 5.27) 2016 Modelled IHME
3.82 (2.67 - 5.27) 2015 Modelled IHME
3.83 (2.72 - 5.28) 2014 Modelled IHME
3.86 (2.73 - 5.33) 2013 Modelled IHME
3.9 (2.79 - 5.39) 2012 Modelled IHME
3.92 (2.81 - 5.41) 2011 Modelled IHME
3.93 (2.80 - 5.43) 2010 Modelled IHME
3.93 (2.79 - 5.49) 2009 Modelled IHME
3.92 (2.76 - 5.44) 2008 Modelled IHME
3.9 (2.73 - 5.43) 2007 Modelled IHME
3.88 (2.71 - 5.37) 2006 Modelled IHME
3.85 (2.69 - 5.31) 2005 Modelled IHME
3.82 (2.66 - 5.28) 2004 Modelled IHME
3.79 (2.60 - 5.23) 2003 Modelled IHME
3.75 (2.56 - 5.18) 2002 Modelled IHME
3.74 (2.55 - 5.25) 2001 Modelled IHME
3.75 (2.57 - 5.30) 2000 Modelled IHME
3.76 (2.54 - 5.31) 1999 Modelled IHME
3.75 (2.51 - 5.35) 1998 Modelled IHME
3.76 (2.52 - 5.39) 1997 Modelled IHME
3.78 (2.53 - 5.39) 1996 Modelled IHME
3.8 (2.54 - 5.41) 1995 Modelled IHME
3.82 (2.57 - 5.40) 1994 Modelled IHME
3.85 (2.62 - 5.41) 1993 Modelled IHME
3.89 (2.66 - 5.50) 1992 Modelled IHME
3.92 (2.70 - 5.55) 1991 Modelled IHME
3.93 (2.73 - 5.54) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
8 (6 - 11) 2019 Modelled IHME
8 (6 - 11) 2018 Modelled IHME
8 (5 - 11) 2017 Modelled IHME
8 (5 - 11) 2016 Modelled IHME
8 (5 - 10) 2015 Modelled IHME
7 (5 - 10) 2014 Modelled IHME
7 (5 - 10) 2013 Modelled IHME
7 (5 - 10) 2012 Modelled IHME
7 (5 - 10) 2011 Modelled IHME
7 (5 - 10) 2010 Modelled IHME
7 (5 - 10) 2009 Modelled IHME
7 (5 - 10) 2008 Modelled IHME
7 (5 - 10) 2007 Modelled IHME
7 (5 - 10) 2006 Modelled IHME
7 (5 - 9) 2005 Modelled IHME
7 (5 - 9) 2004 Modelled IHME
7 (5 - 9) 2003 Modelled IHME
7 (4 - 9) 2002 Modelled IHME
7 (4 - 9) 2001 Modelled IHME
6 (4 - 9) 2000 Modelled IHME
6 (4 - 9) 1999 Modelled IHME
6 (4 - 9) 1998 Modelled IHME
6 (4 - 9) 1997 Modelled IHME
6 (4 - 9) 1996 Modelled IHME
6 (4 - 9) 1995 Modelled IHME
6 (4 - 9) 1994 Modelled IHME
6 (4 - 9) 1993 Modelled IHME
6 (4 - 9) 1992 Modelled IHME
6 (4 - 9) 1991 Modelled IHME
6 (4 - 9) 1990 Modelled IHME
2 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
19 (13 - 26) 2019 Modelled IHME
19 (13 - 26) 2018 Modelled IHME
19 (13 - 26) 2017 Modelled IHME
19 (13 - 26) 2016 Modelled IHME
19 (13 - 26) 2015 Modelled IHME
19 (13 - 26) 2014 Modelled IHME
19 (13 - 26) 2013 Modelled IHME
19 (13 - 26) 2012 Modelled IHME
20 (13 - 26) 2011 Modelled IHME
19 (13 - 26) 2010 Modelled IHME
19 (13 - 26) 2009 Modelled IHME
19 (13 - 26) 2008 Modelled IHME
19 (13 - 26) 2007 Modelled IHME
19 (13 - 26) 2006 Modelled IHME
19 (13 - 26) 2005 Modelled IHME
19 (13 - 26) 2004 Modelled IHME
19 (13 - 26) 2003 Modelled IHME
19 (13 - 26) 2002 Modelled IHME
19 (13 - 26) 2001 Modelled IHME
19 (13 - 25) 2000 Modelled IHME
19 (13 - 26) 1999 Modelled IHME
19 (13 - 26) 1998 Modelled IHME
19 (13 - 26) 1997 Modelled IHME
19 (13 - 26) 1996 Modelled IHME
19 (13 - 26) 1995 Modelled IHME
19 (13 - 26) 1994 Modelled IHME
19 (13 - 26) 1993 Modelled IHME
19 (13 - 26) 1992 Modelled IHME
19 (13 - 26) 1991 Modelled IHME
19 (13 - 26) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
16
2019
(12 - 21)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
8
2019
(6 - 11)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
65 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines